By SARA ROBERTSON Recently you may have heard of the push to have COVID-19 survivors donate their plasma in an attempt to treat those who are currently afflicted by the virus. The idea behind this experimental treatment, as described by CNN, is that antibodies in the blood plasma of recovered patients could potentially help people fight off COVID-19.  Plasma comprises about 55% of your blood composition and it carries salts and enzymes. It also carries “antibodies, clotting factors, and the proteins albumin and fibrinogen,” according to Stanford Children’s Hospital. The components that plasma carries can be isolated from the rest of…
Operational Resilience: At Its Core, It’s ‘Business Continuity Done Right’
As part of a global company that helps organizations prepare for disruption, we get the unique opportunity to hear about...
READ MORE >
The Newest Tool in the Risk Assessment Toolbox: The National Risk Index
A key feature of a business continuity plan is a risk assessment. This determines the external risks to your business...
READ MORE >
20 Years of Lessons From 9/11
This year is the 20th anniversary of the 9/11 attacks. The attack demolished the World Trade Center Towers, damaged the...
READ MORE >
Can Businesses Weather Another Busy Hurricane Season Amid COVID-19’s Impacts?
The greatest mistake businesses make with hurricane preparedness is failing to prepare because they believe their operations won’t be affected....
READ MORE >